Title of Invention	"NOVEL ANTIMICROBIALS"
Abstract	The present invention relates to novel phenyl oxazolidinone compounds of formula I, their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of formula I or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of formula I and methods of using them. The compounds of the present invention are useful as antimicrobial agents, effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant species of Staphylococcus, Streptococcus, Enterococcus, Bacterioides, Clostridia, H. influenza, Moraxella, acid-fast organisms such as Mycobacterium tuberculosis as well as Linezolid resistant species of Staphylococcus and Enterococcus. T ^ R2 R Y" Formula I 87

Title of Invention

"NOVEL ANTIMICROBIALS"

Abstract

The present invention relates to novel phenyl oxazolidinone compounds of formula I, their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of formula I or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of formula I and methods of using them. The compounds of the present invention are useful as antimicrobial agents, effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant species of Staphylococcus, Streptococcus, Enterococcus, Bacterioides, Clostridia, H. influenza, Moraxella, acid-fast organisms such as Mycobacterium tuberculosis as well as Linezolid resistant species of Staphylococcus and Enterococcus. T ^ R2 R Y" Formula I 87

Full Text

Documents:

http://ipindiaonline.gov.in/patentsearch/GrantedSearch/viewdoc.aspx?id=ozwIuUIt4lOLdgnsqUSjPQ==&loc=+mN2fYxnTC4l0fUd8W4CAA==

« Previous Patent

Next Patent »

Patent Number

269311

Indian Patent Application Number

2623/DEL/2008

PG Journal Number

42/2015

Publication Date

16-Oct-2015

Grant Date

15-Oct-2015

Date of Filing

20-Nov-2008

Name of Patentee

PANACEA BIOTEC LIMITED

Applicant Address

B-1 EXTN.A/27 MOHAN CO-OPERATIVE, INDUSTRIAL ESTATE, MATHURA ROAD, NEW DELHI-110044

Inventors:

#	Inventor's Name	Inventor's Address
1	JAIN, RAJESH	B-1 EXTN.A/27 MOHAN CO-OPERATIVE, INDUSTRIAL ESTATE, MATHURA ROAD, NEW DELHI-110044
2	TREHAN, SANJAY	B-1 EXTN.A/27 MOHAN CO-OPERATIVE, INDUSTRIAL ESTATE, MATHURA ROAD, NEW DELHI-110044
3	DAS, JAGATTARAN	B-1 EXTN.A/27 MOHAN CO-OPERATIVE, INDUSTRIAL ESTATE, MATHURA ROAD, NEW DELHI-110044
4	KANWAR, SANDEEP	B-1 EXTN.A/27 MOHAN CO-OPERATIVE, INDUSTRIAL ESTATE, MATHURA ROAD, NEW DELHI-110044
5	MAGADI, SITARAM, KUMAR	B-1 EXTN.A/27 MOHAN CO-OPERATIVE, INDUSTRIAL ESTATE, MATHURA ROAD, NEW DELHI-110044
6	SHARMA, SUDHIR, KUMAR	B-1 EXTN.A/27 MOHAN CO-OPERATIVE, INDUSTRIAL ESTATE, MATHURA ROAD, NEW DELHI-110044

PCT International Classification Number

C07D

PCT International Application Number

N/A

PCT International Filing date

PCT Conventions:

#	PCT Application Number	Date of Convention	Priority Country
1			NA